{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:34:21Z","timestamp":1773747261403,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1007229","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000}}],"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000121","name":"Division of Mathematical Sciences","doi-asserted-by":"publisher","award":["DMS-1714654"],"award-info":[{"award-number":["DMS-1714654"]}],"id":[{"id":"10.13039\/100000121","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI028433"],"award-info":[{"award-number":["R01-AI028433"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-OD011095"],"award-info":[{"award-number":["R01-OD011095"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01-AI131365"],"award-info":[{"award-number":["P01-AI131365"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI114448"],"award-info":[{"award-number":["AI114448"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI068636"],"award-info":[{"award-number":["UM1 AI068636"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI068634 (SDAC)"],"award-info":[{"award-number":["AI068634 (SDAC)"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1007229","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T17:25:43Z","timestamp":1563989143000},"page":"e1007229","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1474-4230","authenticated-orcid":true,"given":"Jessica M.","family":"Conway","sequence":"first","affiliation":[]},{"given":"Alan S.","family":"Perelson","sequence":"additional","affiliation":[]},{"given":"Jonathan Z.","family":"Li","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","volume":"96","author":"RT Davey Jr","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref2","first-page":"343","article-title":"The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption","volume":"30","author":"JZ Li","year":"2016","journal-title":"AIDS"},{"key":"ref3","article-title":"The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies","author":"G Namazi","year":"2018","journal-title":"J Infect Dis"},{"key":"ref4","article-title":"HIV-1 proviral landscapes distinguish post-treatment controllers from non-controllers","author":"R Sharaf","year":"2018","journal-title":"J Clin Investig"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e1003211","DOI":"10.1371\/journal.ppat.1003211","article-title":"Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study","volume":"9","author":"A S\u00e1ez-Ciri\u00f3n","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/433188","article-title":"HIV controllers: A homogeneous group of HIV-1-infected patients with spontaneous control of viral replication","volume":"41","author":"O Lambotte","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.antiviral.2009.08.007","article-title":"Effector Mechanisms in HIV-1 infected elite controllers: Highly active immune response?","volume":"85","author":"JN Blankson","year":"2010","journal-title":"Antivir Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/QAD.0000000000000658","article-title":"The critical roles of treatment interruption studies and biomarker identification in the search for an HIV cure","volume":"29","author":"JZ Li","year":"2015","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/QAD.0000000000001118","article-title":"Unite forces to validate biomarkers in the quest for lasting HIV remission","volume":"30","author":"C Rokx","year":"2016","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e03821","DOI":"10.7554\/eLife.03821","article-title":"HIV-1 DNA predicts disease progression and post-treatment virological control","volume":"3","author":"JP Williams","year":"2014","journal-title":"eLife"},{"key":"ref11","unstructured":"Etemad B, Sun X, Lederman MM, Gottlieb RZ, Aga E, Bosch R, et al. Viral and immune characteristics of HIV post-treatment controllers in ACTG studies. In: Conference on Retroviruses and Opportunistic Infections (CROI); 2016."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/QAD.0000000000001382","article-title":"Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection","volume":"31","author":"GE Martin","year":"2017","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1038\/ncomms9495","article-title":"Immunological biomarkers predict HIV-1 viral rebound after treatment interruption","volume":"6","author":"J Hurst","year":"2015","journal-title":"Nat Commun"},{"key":"ref14","article-title":"Virus dynamics: Mathematical principles of immunology and virology","author":"MA Nowak","year":"2001"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri700","article-title":"Modelling viral and immune system dynamics","volume":"2","author":"AS Perelson","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics <italic>in vivo<\/italic>: Virion clearance rate, infected cell life-span, and viral generation time","volume":"271","author":"AS Perelson","year":"1996","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/387188a0","article-title":"Decay characteristics of HIV-1 infected compartments during combination Therapy","volume":"387","author":"AS Perelson","year":"1997","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1137\/S0036144598335107","article-title":"Mathematical analysis of HIV-I: Dynamics in vivo","volume":"41","author":"AS Perelson","year":"1999","journal-title":"SIAM Rev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/jtbi.2000.1076","article-title":"Modeling plasma virus concentration during primary HIV infection","volume":"203","author":"MA Stafford","year":"2000","journal-title":"J Theor Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1741-7007-11-96","article-title":"Modeling the within-host dynamics of HIV infection","volume":"11","author":"AS Perelson","year":"2013","journal-title":"BMC Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1002033","DOI":"10.1371\/journal.pcbi.1002033","article-title":"A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients","volume":"7","author":"JM Conway","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1137\/120876800","article-title":"Stochastic analysis of pre- and postexposure prophylaxis against HIV infection","volume":"73","author":"JM Conway","year":"2013","journal-title":"SIAM J Appl Math"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1073\/pnas.1419162112","article-title":"Post-treatment control of HIV infection","volume":"112","author":"JM Conway","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e1004677","DOI":"10.1371\/journal.pcbi.1004677","article-title":"Residual viremia in treated HIV+ individuals","volume":"12","author":"JM Conway","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1128\/JVI.77.8.5037-5038.2003","article-title":"A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo","volume":"77","author":"M Markowitz","year":"2003","journal-title":"J Virol"},{"key":"ref26","first-page":"1782","article-title":"Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis","volume":"354","author":"B Ramratnam","year":"1999","journal-title":"Lancet Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"19079","DOI":"10.1073\/pnas.0707449104","article-title":"Determination of virus burst size <italic>in vivo<\/italic> using a single-cycle SIV in rhesus macaques","volume":"104","author":"HY Chen","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"13475","DOI":"10.1073\/pnas.1406663111","article-title":"Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1","volume":"111","author":"AL Hill","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e1005535","DOI":"10.1371\/journal.ppat.1005535","article-title":"Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV","volume":"12","author":"AL Hill","year":"2016","journal-title":"PLoS Pathog"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1005000","DOI":"10.1371\/journal.ppat.1005000","article-title":"HIV reactivation from latency after treatment interruption occurs on average every 5-8 Days\u2014implications for HIV remission","volume":"11","author":"M Pinkevych","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e1005740","DOI":"10.1371\/journal.ppat.1005740","article-title":"Modeling of experimental data supports HIV reactivation from latency after treatment interruption on average once every 5-8 days","volume":"12","author":"M Pinkevych","year":"2016","journal-title":"PLoS Pathog"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e1006359","DOI":"10.1371\/journal.ppat.1006359","article-title":"Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy","volume":"13","author":"CM Fennessey","year":"2017","journal-title":"PLOS Pathogens"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e1005679","DOI":"10.1371\/journal.ppat.1005679","article-title":"Insufficient evidence for rare activation of latent HIV in the absence of reservoir-reducing interventions","volume":"12","author":"AL Hill","year":"2016","journal-title":"PLoS Pathog"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"eaan8848","DOI":"10.1126\/scitranslmed.aan8848","article-title":"A randomized controlled safety\/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection","volume":"9","author":"MC Sneller","year":"2017","journal-title":"Sci Transl Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/QAD.0b013e32832eb285","article-title":"Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment","volume":"23","author":"P Volberding","year":"2009","journal-title":"AIDS"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1086\/509508","article-title":"A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024)","volume":"194","author":"JM Kilby","year":"2006","journal-title":"J Infect Dis"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/506364","article-title":"Evidence that intermittent structured treatment interruption, but not Immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: The results of AIDS Clinical Trials Group 5068","volume":"194","author":"JM Jacobson","year":"2006","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1086\/512681","article-title":"Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: A prospective study by AIDS Clinical Trials Group 5170","volume":"195","author":"DJ Skiest","year":"2007","journal-title":"J Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e10555","DOI":"10.1371\/journal.pone.0010555","article-title":"Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute\/early HIV-1 infection","volume":"5","author":"ES Rosenberg","year":"2010","journal-title":"PLoS ONE"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/655468","article-title":"AIDS Clinical Trials Group 5197: A placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 Core Protein","volume":"202","author":"RT Schooley","year":"2010","journal-title":"J Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Hataye JM, Casazza JP, Best K, Liang J, Ambrozak DR, Darko S, et al. Principles governing establishment versus collapse of HIV-1 cellular spread. Submitted. 2018.","DOI":"10.1016\/j.chom.2019.10.006"},{"key":"ref42","first-page":"e10052371","article-title":"Modeling the effects of vorinostat in vivo reveals both transient and delayed HIV transcriptional activation and minimal killing of latently infected cells","volume":"11","author":"R Ke","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/infdis\/jiv218","article-title":"Precise quantitation of the latent HIV-1 reservoir: Implications for eradication strategies","volume":"212","author":"AM Crooks","year":"2015","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaci.2014.05.026","article-title":"Recent developments in the search for a cure for HIV-1 infection: Targeting the latent reservoir for HIV-1","volume":"134","author":"JD Siliciano","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"N Chomont","year":"2009","journal-title":"Nat Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"YC Ho","year":"2013","journal-title":"Cell"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12977-018-0397-2","article-title":"What do we measure when we measure cell-associated HIV RNA","volume":"15","author":"AO Pasternak","year":"2018","journal-title":"Retrovirology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/499364","article-title":"Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: An adult AIDS Clinical Trials Group Study","volume":"42","author":"HJ Ribaudo","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1023\/A:1011907920641","article-title":"Modeling of pharmacokinetic\/pharmacodynamic (PK\/PD) relationships: concepts and perspectives","volume":"16","author":"H Derendorf","year":"1999","journal-title":"Pharmaceutical research"},{"issue":"9","key":"ref50","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/nm.2892","article-title":"Antiretroviral dynamics determines HIV evolution and predicts therapy outcome","volume":"18","author":"DIS Rosenbloom","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/11318110-000000000-00000","article-title":"Intracellular pharmacokinetics of antiretroviral drugs in HIV-infected patients, and their correlation with drug action","volume":"49","author":"C Bazzoli","year":"2010","journal-title":"Clinical Pharmacokinetics"},{"key":"ref52","article-title":"Model selection and multimodel inference: A practical information-theoretic approach","author":"KP Burnham","year":"2003"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JVI.02139-15","article-title":"Origin of rebound plasma HIV includes cells with identical proviruses that are transcriptionally active before stopping of antiretroviral therapy","volume":"90","author":"MF Kearney","year":"2016","journal-title":"J Virol"},{"key":"ref54","unstructured":"Luebeck G, Meza R. Bhat: General likelihood exploration; 2015."},{"issue":"7","key":"ref55","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm1777","article-title":"Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs","volume":"14","author":"L Shen","year":"2008","journal-title":"Nat Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1289\/ehp.8563195","article-title":"Multistage models of carcinogenesis","volume":"63","author":"P Armitage","year":"1985","journal-title":"Environ Health Perspect"},{"issue":"17","key":"ref57","doi-asserted-by":"crossref","first-page":"8963","DOI":"10.1128\/JVI.76.17.8963-8965.2002","article-title":"Decelerating decay of latently infected cells during prolonged therapy fo human immunodeficiency virus type 1 infection","volume":"76","author":"V M\u00fcller","year":"2002","journal-title":"J Virol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1073\/pnas.0736332100","article-title":"Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence","volume":"100","author":"MC Strain","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1086\/428777","article-title":"Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1","volume":"191","author":"MC Strain","year":"2005","journal-title":"J Infect Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells","volume":"345","author":"F Maldarelli","year":"2014","journal-title":"Science (New York, NY)"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jtbi.2009.06.011","article-title":"Modeling HIV Persistence, the latent reservoir, and viral blips","volume":"260","author":"L Rong","year":"2009","journal-title":"J Theor Biol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"E1126","DOI":"10.1073\/pnas.1414926112","article-title":"Large number of rebounding\/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption","volume":"112","author":"MK Rothenberger","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref63","first-page":"121","article-title":"HIV Infection: Advances Toward a Cure","volume":"25","author":"DC Douek","year":"2018","journal-title":"Topics in antiviral medicine"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"L32","DOI":"10.1016\/j.bpj.2010.03.001","article-title":"Transcriptional bursting from the HIV-1 promoter is a significant source of stochastic noise in HIV-1 gene expression","volume":"98","author":"A Singh","year":"2010","journal-title":"Biophys J"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.cell.2015.02.009","article-title":"A hardwired HIV latency program","volume":"160","author":"BS Razooky","year":"2015","journal-title":"Cell"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"12453","DOI":"10.1073\/pnas.1811195115","article-title":"Probabilistic control of HIV latency and transactivation by the Tat gene circuit","volume":"115","author":"Y Cao","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3851\/IMP2273","article-title":"HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy","volume":"17","author":"C Goujard","year":"2012","journal-title":"Antivir Ther"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa1302976","article-title":"Absence of detectable HIV-1 viremia after treatment cessation in an infant","volume":"369","author":"D Persaud","year":"2013","journal-title":"New Engl J Med"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1097\/QAD.0000000000000478","article-title":"Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study","volume":"28","author":"JZ Li","year":"2014","journal-title":"AIDS"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"e1002417","DOI":"10.1371\/journal.pmed.1002417","article-title":"HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study","volume":"14","author":"TJ Henrich","year":"2017","journal-title":"PLOS Med"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1128\/JVI.79.14.9006-9018.2005","article-title":"Changes in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression","volume":"79","author":"RM Troyer","year":"2005","journal-title":"J Virol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1182\/blood-2006-09-044826","article-title":"PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors","volume":"109","author":"JY Zhang","year":"2007","journal-title":"Blood"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature14053","article-title":"Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations","volume":"517","author":"K Deng","year":"2015","journal-title":"Nature"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11538-006-9140-6","article-title":"Estimation and prediction with HIV-treatment interruption data","volume":"69","author":"BM Adams","year":"2007","journal-title":"Bull Math Biol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1073\/pnas.1522675113","article-title":"Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo","volume":"113","author":"FR Simonetti","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref76","doi-asserted-by":"crossref","DOI":"10.1201\/9781315533247","article-title":"Janeway\u2019s Immunobiology","author":"K Murphy","year":"2016"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.it.2007.08.009","article-title":"Do most lymphocytes in humans really reside in the gut?","volume":"28","author":"VV Ganusov","year":"2007","journal-title":"Trends Immunol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"CV Fletcher","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref79","first-page":"1","article-title":"Encyclopedia of AIDS","author":"CV Fletcher","year":"2015"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"JD Siliciano","year":"2003","journal-title":"Nat Med"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007229","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:24:36Z","timestamp":1589001876000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007229"}},"subtitle":[],"editor":[{"given":"Rustom","family":"Antia","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2019,7,24]]},"references-count":80,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007229","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1007229","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,24]]}}}